Softwr

Healthcare · head to head

Sysmex vs Therapixel

Sysmex logo

Sysmex

Healthcare

Haematology and urinalysis analysers sold with the middleware that decides which results a scientist ever sees

From
On request
Rated
-
Full reviewWebsite
Therapixel logo

Therapixel

Healthcare

French mammography AI with FDA clearances for 2D and tomosynthesis breast screening

From
On request
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: Sysmex the middleware is not realistically separable from the instrument contract, so a laboratory that likes Caresphere but wants another vendor analyser has no clean path to buying just the software.; Therapixel european and American regulatory positions were established under different regimes, and under the EU Medical Device Regulation this class of diagnostic AI faces a higher classification and notified body scrutiny, so European buyers must verify the current MDR certificate and expiry rather than relying on a legacy CE reference.
  • They diverge on capability: Sysmex covers Caresphere autovalidation, Therapixel covers MammoScreen 2D.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Sysmex and Therapixel actually diverge.

Attributes where Sysmex and Therapixel differ
AttributeSysmexTherapixel
PlatformsWeb, Windows, On-premiseWeb

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Sysmex

  • Caresphere autovalidation
  • Delta and moving average QC
  • WAM rule sets
  • Fleet telemetry
  • Reagent inventory tracking
  • Extended white cell parameters
  • LIS interfacing
  • Multi-site harmonisation

Only in Therapixel

  • MammoScreen 2D
  • MammoScreen DBT
  • One to ten suspicion score
  • Summary report
  • Workstation and PACS delivery
  • Reading workflow configurations

What people use each for

The jobs each tool is most often brought in to do.

Sysmex

  • A hospital network standardising full blood count reporting across six laboratories so a result released at a district hospital carries the same rules as the tertiary centrenot Therapixel
  • A pathology group trying to raise autovalidation rates to absorb rising demand without recruiting more biomedical scientistsnot Therapixel
  • A blood sciences service consolidating haematology, coagulation and urinalysis onto one middleware layer to remove three separate QC workflowsnot Therapixel
  • A laboratory running 24 hour service that needs remote analyser telemetry so an overnight fault is triaged before the morning shift arrivesnot Therapixel

Therapixel

  • A European breast screening programme running mandatory double reading that wants to evaluate AI as a concurrent or second reader within what national guidance permitsnot Sysmex
  • An American breast centre that has moved to tomosynthesis and needs reading support on DBT specifically, which Therapixel holds a clearance fornot Sysmex
  • A screening service wanting a graded suspicion score rather than a binary flag so readers can calibrate their own thresholdnot Sysmex
  • A radiology group evaluating multiple mammography AI vendors head to head on their own historic case set before committingnot Sysmex

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Sysmex

  • The middleware is not realistically separable from the instrument contract, so a laboratory that likes Caresphere but wants another vendor analyser has no clean path to buying just the software.
  • Reagent rental agreements set a minimum annual test volume, and a laboratory whose activity falls after a service reconfiguration keeps paying against a floor it no longer reaches.
  • Regulatory clearance is granted per parameter and per region, so a flag or extended parameter that a European laboratory relies on may not be released for clinical use on the same analyser in the United States.
  • Interfacing to a non-Sysmex laboratory information system is a project, not a configuration step, and integration effort is often quoted separately from the instrument contract.
  • Autovalidation rule sets are configured locally, so the gains depend entirely on whether the laboratory has the clinical governance capacity to write, validate and audit those rules; buying the software does not deliver the saving on its own.

Therapixel

  • European and American regulatory positions were established under different regimes, and under the EU Medical Device Regulation this class of diagnostic AI faces a higher classification and notified body scrutiny, so European buyers must verify the current MDR certificate and expiry rather than relying on a legacy CE reference.
  • MammoScreen does mammography only, so a hospital wanting AI across head CT, chest and breast needs several vendors and several PACS integrations, or an orchestration layer bought from someone else.
  • Therapixel is a small French company competing against Hologic and iCAD, which have incumbency inside the mammography reading workstation, so integration into an American breast centre is more work than it is for the workstation vendor own AI.
  • Detection performance is sensitive to the mammography unit vendor and acquisition protocol, so published results do not transfer between estates and each site needs local validation it must fund itself.
  • Whether AI can substitute for one of two human readers is a national workforce and liability question, not a product capability, so the labour saving that justifies the purchase in one country is not permitted in another.

Pricing, plan by plan

Sysmex

On request
  • Reagent rental or cost per reportable result contract$undefined/year
    • Analyser hardware, reagents, service and Caresphere middleware bundled into a price per test
    • Five to seven year term typical
    • Minimum annual test volume commitment

Therapixel

On request
  • MammoScreen$undefined/year
    • Priced per examination or by annual screening volume
    • 2D and tomosynthesis licensed by the versions cleared for each
    • Cloud or on premises deployment quoted differently

Which should you pick?

Choose Sysmex if

  • You need caresphere autovalidation.
  • You work on Web, Windows, On-premise.
  • You also want delta and moving average qc.
Sysmex review

Choose Therapixel if

  • You need mammoscreen 2d.
  • You also want mammoscreen dbt.
Therapixel review

Questions people ask

Is Sysmex or Therapixel better?
Neither clearly leads. Sysmex starts at On request and Therapixel at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Sysmex or Therapixel?
Sysmex starts at On request and Therapixel at On request.
Does Sysmex or Therapixel run on more platforms?
Sysmex runs on Web, Windows, On-premise. Therapixel runs on Web.
What is Sysmex best used for?
Sysmex is most often used for a hospital network standardising full blood count reporting across six laboratories so a result released at a district hospital carries the same rules as the tertiary centre, a pathology group trying to raise autovalidation rates to absorb rising demand without recruiting more biomedical scientists, a blood sciences service consolidating haematology, coagulation and urinalysis onto one middleware layer to remove three separate qc workflows, a laboratory running 24 hour service that needs remote analyser telemetry so an overnight fault is triaged before the morning shift arrives. Of those, a hospital network standardising full blood count reporting across six laboratories so a result released at a district hospital carries the same rules as the tertiary centre and a pathology group trying to raise autovalidation rates to absorb rising demand without recruiting more biomedical scientists are not what Therapixel is typically brought in for.
What can Sysmex do that Therapixel cannot?
Sysmex covers Caresphere autovalidation, Delta and moving average QC, WAM rule sets, Fleet telemetry. Therapixel covers MammoScreen 2D, MammoScreen DBT, One to ten suspicion score, Summary report.

Answered from the vendors’ own pages

Sysmex: Can I buy Caresphere without Sysmex analysers?

Not in practice. It is licensed as part of the instrument and reagent agreement, and its value depends on Sysmex-specific parameters and flags.

Therapixel: Is MammoScreen FDA cleared?

Yes. It holds 510(k) clearance K192854 for two dimensional mammography from July 2020, a November 2021 clearance for digital breast tomosynthesis, and two further clearances in October 2024 for later versions.

Sysmex: Is Sysmex software FDA cleared?

Clearance attaches to the analysers and to individual reported parameters, not to the middleware as a whole. Check the specific parameter and the specific market, because clearances differ between the United States, Europe and Japan.

Therapixel: Is it CE marked?

Yes, but European buyers should ask specifically for the current certificate under the Medical Device Regulation and its expiry date, because this class of diagnostic AI moved to a higher classification under MDR.

Sysmex: How is it priced?

Per reportable result, or as a reagent rental with a minimum annual volume. There is no per user or per seat price.

Therapixel: What does the one to ten score mean?

It is a graded suspicion score per finding and per study, designed to be integrated alongside a radiologist BI-RADS assessment rather than treated as a positive or negative result.

Sysmex: What is the contract length?

Typically five to seven years, aligned to instrument depreciation, with reagent pricing fixed or indexed over the term.

Therapixel: Does it cover anything besides mammography?

No. It is a mammography product only, including tomosynthesis. Other body regions need a different vendor.

Share

Related pages

More on Sysmex

More on Therapixel

Keep looking

Other head to heads